Stay updated on Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Metastatic Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier was updated from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record describes a completed Phase 3 study comparing CT-P6 with Herceptin, each combined with paclitaxel, for metastatic breast cancer. It also provides the study’s eligibility criteria, outcome measures, participating location, and record dates.SummaryDifference47%

- Check22 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide banner announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision label updates from v3.7.1 to v3.7.2 on the study-record error page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metastatic Breast Cancer Clinical Trial page.